Aptus Pharma
add_icon

Aptus Pharma

215.10
+0.85
(0.40%)
Market Cap
147.58 Cr
PE Ratio
-
Volume
16,000.00
Day High - Low
215.10 - 207.10
52W High-Low
228.90 - 80.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
147.58 Cr
EPS
6.37
PE Ratio
-
PB Ratio
7.35
Book Value
29.13
EBITDA
4.90
Dividend Yield
0.00 %
Return on Equity
44.50
Debt to Equity
1.79
Forecast For
Actual

Company News

View All News
Caret
negative
Competition Commission of India defends global turnover-based penalty law in court, opposing Apple's challenge that could result in up to $38 billion fine for alleged app store dominance misuse.
positive
Morgan Stanley forecasts Apple will introduce Samsung-supplied 200MP cameras in iPhone 21 Pro models by 2028, with production potentially shifting to Samsung's Austin facility.
positive
Apple reportedly planning iPhone 17e launch for February 2026 with 120Hz OLED display, A19 chip, 48MP camera, and budget-friendly pricing starting around Rs 64,000 in India.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,392.60
#1 94,525.84
43.09
#1 24,630.60
14.26
#1 2,203
#1 64,800.00
27.89
1,438.00
47,581.23
89.91
15,737.30
23.58
834
-76.28
60.21
1,813.60
37,290.30
67.49
12,042.70
23.73
591
2.81
50.13
6,137.00
21,585.08
94.26
10,046.60
#1 48.08
251
-252.86
33.45
255.00
16,419.83
33.67
7,932.40
7.48
564
-41.14
43.69
303.30
13,234.33
47.04
5,598.70
14.48
314
3.00
30.75
573.80
11,097.50
59.28
2,451.50
11.53
164
31.87
32.78
803.60
10,195.42
#1 29.20
8,110.20
15.97
363
-21.87
22.41
598.80
8,200.62
78.32
2,789.50
1.31
108
20.84
32.59
908.30
6,237.42
47.78
1,622.70
34.46
213
-66.07
56.09
Growth Rate
Revenue Growth
37.43 %
Net Income Growth
287.50 %
Cash Flow Change
15.21 %
ROE
-1.51 %
ROCE
105.69 %
EBITDA Margin (Avg.)
127.53 %

Yearly Financial Results

Annual Financials
2023
2024
2025
TTM
Revenue
14
18
25
0
Expenses
13
16
20
0
EBITDA
1
2
5
0
Operating Profit %
4 %
9 %
20 %
0 %
Depreciation
0
0
0
0
Interest
0
0
1
0
Profit Before Tax
0
1
4
0
Tax
0
0
1
0
Net Profit
0
1
3
0
EPS in ₹
1.30
5.32
6.37
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
6
10
22
Fixed Assets
1
1
1
Current Assets
6
8
20
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
6
9
21
Total Liabilities
6
10
22
Current Liabilities
3
4
12
Non Current Liabilities
2
4
3
Total Equity
1
2
7
Reserve & Surplus
1
2
2
Share Capital
0
0
5

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
0
4
Investing Activities
-0
-0
-1
Operating Activities
-0
-2
-2
Financing Activities
1
3
7

Share Holding

% Holding
Jun 2025
Sept 2025
Dec 2025
Promoter
72.89 %
72.89 %
72.89 %
FIIs
10.03 %
10.03 %
0.00 %
DIIs
2.80 %
2.80 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
11.55 %
11.55 %
22.97 %
Others
2.74 %
2.74 %
4.14 %
No of Share Holders
9
9
302

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 129.20 145.50

Technical Indicators

RSI(14)
Neutral
78.04
ATR(14)
Volatile
8.07
STOCH(9,6)
Overbought
91.74
STOCH RSI(14)
Overbought
88.99
MACD(12,26)
Bullish
4.28
ADX(14)
Strong Trend
34.91
UO(9)
Bearish
68.56
ROC(12)
Uptrend And Accelerating
33.91
WillR(14)
Overbought
-19.96